NATHBIOGEN.BONATHBIOGEN.BO
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-86.29%
↓ 127% below average
Average (39q)
318.90%
Historical baseline
Range
High:6129.45%
Low:-1024.24%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -86.29% |
| Q2 2025 | 4120.36% |
| Q1 2025 | -112.87% |
| Q4 2024 | 80.83% |
| Q3 2024 | -88.83% |
| Q2 2024 | 179.09% |
| Q1 2024 | -1024.24% |
| Q4 2023 | 1.45% |
| Q3 2023 | -86.64% |
| Q2 2023 | 974.88% |
| Q1 2023 | -32.92% |
| Q4 2022 | 16.82% |
| Q3 2022 | -87.33% |
| Q2 2022 | 254.27% |
| Q1 2022 | -510.66% |
| Q4 2021 | 42.47% |
| Q3 2021 | -92.18% |
| Q2 2021 | 424.66% |
| Q1 2021 | 37.38% |
| Q4 2020 | 28.20% |
| Q3 2020 | -88.10% |
| Q2 2020 | 719.32% |
| Q1 2020 | -6.78% |
| Q4 2019 | 14.71% |
| Q3 2019 | -86.64% |
| Q2 2019 | 1160.31% |
| Q1 2019 | -50.89% |
| Q4 2018 | 25.40% |
| Q3 2018 | -82.65% |
| Q2 2018 | 705.73% |
| Q1 2018 | -13.09% |
| Q4 2017 | 9.52% |
| Q3 2017 | -84.42% |
| Q2 2017 | 6129.45% |
| Q1 2017 | -91.43% |
| Q4 2016 | 80.39% |
| Q3 2016 | -87.17% |
| Q2 2016 | 797.29% |
| Q1 2016 | -444.73% |
| Q4 2015 | 111.37% |